STEP vs TMO · rev $1.99B vs P/E 24, rev $44.56B
Stepstone Group Inc (STEP) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Stepstone Group Inc (STEP) is a asset management company listed on NASDAQ.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported STEP revenue for 2026-03-31 was $1.99B. Net income was -$535.8M. Revenue was up 69.7% from 2025-03-31 to 2026-03-31. STEP currently screens at market cap $5.78B.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
STEP currently screens at market cap $5.78B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the STEP and TMO stock pages for the full models.
Not investment advice.